Patient-reported outcomes (PROs) in the double-blind phase 3 trial (NGR015) with NGR-hTNF plus best investigator choice (BIC) versus placebo plus BIC for previously treated patients with malignant pleural mesothelioma (MPM).

Medientyp: E-Artikel

Titel: Patient-reported outcomes (PROs) in the double-blind phase 3 trial (NGR015) with NGR-hTNF plus best investigator choice (BIC) versus placebo plus BIC for previously treated patients with malignant pleural mesothelioma (MPM)

Beteiligte: Gregorc, Vanesa; Bulotta, Alessandra; Viganò, Maria G; Citterio, Giovanni; Petrella, Giovanna; Brioschi, Elena; Ducceschi, Monika; Gianni, Luca; Colombi, Scialini; Rossoni, Gloria; Salini, Giulia; Savia, Veronica; Lambiase, Antonio; Bordignon, Claudio

Erschienen: American Society of Clinical Oncology (ASCO), 2016

Sprache: Englisch

DOI: 10.1200/jco.2016.34.15_suppl.e20077

ISSN: 0732-183X; 1527-7755

Schlagwörter: Cancer Research ; Oncology

Entstehung:

Anmerkungen:

Zugangsstatus: Freier Zugang

Nur in Feld suchen:

Zuletzt gesuchte Begriffe: